Short-Term Psychodynamic Psychotherapy in Patients with “Male Depression” Syndrome, Hopelessness, and Suicide Risk: A Pilot Study

Table 1

Outcomes.

Variables		Estimated differences; (M ± SE)	𝑃<	Effect size; (partial eta squared)
Men—%	14.3
Women—%	85.7
Age—M ± SD	40.00 ± 12.57
Therapy duration—months	7.21 ± 2.03
Baseline BHS—M ± SD	10.53 ± 4.90	−0.92 ± 1.55	0.57	0.03
Follow-up BHS—M ± SD	9.03 ± 5.17
Baseline GMDS—M ± SD	23.57 ± 6.06	−9.08 ± 2.74	0.01	0.50
Follow-up GMDS—M ± SD	15.54 ± 8.89

Multivariate test of within subject effect: Wilks' 𝜆=0.49; 𝐹_2;10 = 5.11; 𝑃<0.05; 𝜂²_𝑝=0.51.
GMDS ≤ 13: no depression; GMDS between 13 and 26: moderate depression; GMDS > 26: severe depression. BHS ≤ 3: no hopelessness; BHS between 4 and 8: mild hopelessness; BHS ≥ 9 moderate- to- severe hopelessness.